BioSpace News Archive

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting results of its collaboration with the Microbiology Laboratory of the Queen Elizabeth Hospital of Health PEI (“ Health PEI ”), in support of provincial adoption of molecular diagnostic (“ MDx ”) screening for Human Papillomavirus (“ HPV ”) infections.

Singular Genomics Systems, Inc. today announced the launch of its Max Read™ Kits for single cell applications on the company’s G4 Sequencing Platform at the Advances in Genome Biology and Technology (AGBT) 23rd General Meeting, taking place February 6–9, 2023, in Hollywood, Florida.

AESARA welcomes Cristina Masseria to AESARA bringing over 20 years of experience that spans across multiple therapy areas, research methods, innovation, and corporate leadership further expanding AESARA’s growth.

TransMed7, LLC announced today that the “First in Human” series of clinical cases using commercial production Concorde US devices.

NeoGenomics, Inc. announced today that it plans to release its fourth quarter and full year 2022, financial results on Thursday, February 23, 2023.

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced results of a new study of the RaDaR assay in patients with muscle-invasive bladder cancer immediately following treatment with a combination of the immune checkpoint inhibitors in the neoadjuvant setting.

Heart Test Laboratories, Inc. today announced it has been granted a patent in Israel (Patent No. 10-2490960) from the Israel Patent Office.

Inozyme Pharma, Inc. today announced that it will host an Investor and Analyst Event on Thursday, Feb. 16, 2023 at 8 a.m. ET.

Concerto Biosciences announced today that it has appointed Didier Vingadassalom, Ph.D., MBA, as Senior Director, Business Development.

Organon (NYSE: OGN), a global women’s healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.